Public Profile

Otonomy, Inc.

Otonomy, Inc., a leading biopharmaceutical company based in the United States, focuses on innovative therapies for ear diseases. Founded in 2011, Otonomy has made significant strides in the industry, particularly in the development of treatments for hearing loss and tinnitus. The company’s headquarters is located in San Diego, California, with operations extending across major regions in the US. Otonomy's core products, including OTO-313 and OTO-413, are designed to address unmet medical needs in otology, setting them apart with their unique delivery mechanisms and targeted action. With a commitment to advancing ear health, Otonomy has established a strong market position, recognised for its pioneering research and development efforts. The company continues to push the boundaries of what is possible in the field of ear therapeutics, aiming to improve the quality of life for patients worldwide.

DitchCarbon Score

How does Otonomy, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

18

Industry Average

Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

2

Industry Benchmark

Otonomy, Inc.'s score of 18 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.

0%

Otonomy, Inc.'s reported carbon emissions

Otonomy, Inc., headquartered in the US, currently does not have publicly available carbon emissions data or specific reduction targets. As such, there are no reported figures for their Scope 1, 2, or 3 emissions. The absence of emissions data suggests that Otonomy may still be in the early stages of formalising its climate commitments or reporting practices. Without specific initiatives or targets outlined, it is unclear how the company plans to address its carbon footprint or contribute to broader climate goals within the industry.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Otonomy, Inc.'s primary industry is Health and social work services (85), which is low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Otonomy, Inc. is headquartered in US, which has a rank of low, indicating low grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Otonomy, Inc. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
Carbon Disclosure Project
The Climate Pledge
UN Global Compact

Similar Organizations

Novartis Pharmaceuticals Corporation

US
Chemicals nec
Updated 8 days ago
DitchCarbon Score

Arbor Pharmaceuticals, LLC

US
Chemicals nec
Updated 7 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers